Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Neyarapally GA"'
Autor:
Neyarapally GA; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research (CDER), FDA, Silver Spring, MD, USA. George.neyarapally@fda.hhs.gov., Wu L; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Jefferson, AR, USA., Xu J; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Jefferson, AR, USA., Zhou EH; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research (CDER), FDA, Silver Spring, MD, USA., Dang O; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research (CDER), FDA, Silver Spring, MD, USA., Lee J; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research (CDER), FDA, Silver Spring, MD, USA., Mehta D; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research (CDER), FDA, Silver Spring, MD, USA., Vaughn RD; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research (CDER), FDA, Silver Spring, MD, USA., Pinnow E; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research (CDER), FDA, Silver Spring, MD, USA., Fang H; Office of Scientific Coordination, National Center for Toxicological Research (NCTR), FDA, Jefferson, AR, USA.
Publikováno v:
Drug safety [Drug Saf] 2024 Dec; Vol. 47 (12), pp. 1265-1274. Date of Electronic Publication: 2024 Jul 31.
Autor:
Neyarapally GA; Regulatory Science and Applied Research Team, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, United States., Millikan ED; Office of Medication Error Prevention and Risk Management, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Maryland, United States., Manzo C; Office of Medication Error Prevention and Risk Management, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Maryland, United States.
Publikováno v:
Applied clinical informatics [Appl Clin Inform] 2023 Mar; Vol. 14 (2), pp. 354-355. Date of Electronic Publication: 2023 May 10.
Autor:
Neyarapally GA; Medicaid Pharmacy, NH, USA., Smith MA; Pharmacy Practice, University of Connecticut School of Pharmacy, USA. Electronic address: marie.smith@uconn.edu.
Publikováno v:
Research in social & administrative pharmacy : RSAP [Res Social Adm Pharm] 2017 Jan - Feb; Vol. 13 (1), pp. 214-223. Date of Electronic Publication: 2016 Feb 12.
Autor:
Neyarapally GA
Publikováno v:
Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2014 May-Jun; Vol. 54 (3), pp. 214-5.
Autor:
Hammad TA; Division of Epidemiology, Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA. tarek_hammad@hotmail.com, Neyarapally GA, Iyasu S, Staffa JA, Dal Pan G
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2013 Sep; Vol. 94 (3), pp. 349-58. Date of Electronic Publication: 2013 Jun 05.
Autor:
Lester J; University of Florida College of Pharmacy, Department of Pharmaceutical Outcomes and Policy, 1225 Center Drive, HPNP 3334, Gainesville, FL 32611, USA. jean.lester@fda.hhs.gov, Neyarapally GA, Lipowski E, Graham CF, Hall M, Dal Pan G
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2013 Mar; Vol. 22 (3), pp. 302-5. Date of Electronic Publication: 2013 Jan 02.
Autor:
Hammad TA; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 30993, USA. tarek.hammad@fda.hhs.gov, Neyarapally GA, Pinheiro SP, Iyasu S, Rochester G, Dal Pan G
Publikováno v:
Clinical trials (London, England) [Clin Trials] 2013; Vol. 10 (3), pp. 389-97. Date of Electronic Publication: 2013 Mar 18.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2012 Oct; Vol. 21 (10), pp. 1134-6.
Autor:
Neyarapally GA; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Hammad TA, Pinheiro SP, Iyasu S
Publikováno v:
BMJ open [BMJ Open] 2012 Sep 25; Vol. 2 (5). Date of Electronic Publication: 2012 Sep 25 (Print Publication: 2012).
Autor:
Hammad TA; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. tarek.hammad@fda.hhs.gov, Pinheiro SP, Neyarapally GA
Publikováno v:
Clinical trials (London, England) [Clin Trials] 2011 Oct; Vol. 8 (5), pp. 559-70. Date of Electronic Publication: 2011 Aug 30.